MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial
| Image |  |
|---|---|
| Description | scientific article published on 11 March 2020 |
| Author/s |
author: Hartmut Goldschmidt Katja Weisel |
| Publication date | March 11, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |